EDGAR BOTELLO: Open Payments
NPI 1376164210 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,233 in 180 payments from 22 companies in 2025. Trend: 2023 $2,644 · 2024 $3,514 · 2025 $3,233
Food & beverage: $3,138Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $653 |
| Incyte Corporation | 20 | $400 |
| Janssen Biotech, Inc. | 22 | $272 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $220 |
| UCB, Inc. | 11 | $205 |
| Arcutis Biotherapeutics, Inc. | 15 | $178 |
| Galderma Laboratories, L.P. | 15 | $176 |
| Regeneron Healthcare Solutions, Inc. | 5 | $151 |
| Amgen Inc. | 9 | $138 |
| E.R. Squibb & Sons, L.L.C. | 10 | $135 |
Products named: RINVOQ, OPZELURA, TREMFYA, DUPIXENT, Bimzelx, SKYRIZI, Zoryve, Otezla.
Industry payments across CA — which companies pay providers there.
